We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 198,696 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/2/2018 13:23 | mmmm you cant buy these in any large amount so have to buy small amount on any sells, is this normally the case? | jimmmy | |
09/2/2018 13:18 | The next big drugs tie up is going to be VAL. Imminent RNS confirming a deal with one of the big Pharmas. RNS today letting holders know how many share options the directors have just been awarded. The next one will be the biggy! Broker talks of 30p+ initially on the latest drug test news that is due too. | cudmore | |
09/2/2018 13:18 | Looks like we could be in for an interesting afternoon ... | jakleeds | |
09/2/2018 13:16 | Jim, All matters relating to the Sildenafil patent are in the link below: | hughwilson | |
09/2/2018 13:05 | Jim, I know that the full patent award will not be until 2019. I think the exact date is May 31st but I would have to double check on that. A good explanation is given in the last presentation when Nigel says that the reason that no one had heard of N4 was because of the patent publication had been awaited and now that it had been published N4 were free to talk to partners and investors. | hughwilson | |
09/2/2018 12:31 | OK thanks. The reformulated patents shouldn't be a problem I guess. Nuvec has moved onto the 2nd stage so is going OK. Any idea of time scales for getting fully patent? That would be a big win. At least, feels like it to me. | jimbobaroony | |
09/2/2018 12:14 | Jim, there is a defined process in patent protection before it is signed off but the most important part of that process is that the patent is lodged and published. Once that is done no other company can copy them without infringing on the patent even though the patent is technically pending. | hughwilson | |
09/2/2018 12:01 | OK. I am definitely not an expert on patents so need to understand something. N4p have agreements in place to exclusively license patents from OPAL and Queensland uni. What is the status of those patents? I have been assuming patent pending. Is that wrong? | jimbobaroony | |
09/2/2018 11:47 | PS. One of the things making N4 a prime bid target is that everything they do is fully patented. If any company want to take advantage of N4`s tech, they have to buy them out to get access to their patents. | hughwilson | |
09/2/2018 11:44 | Jim, the difference is that they have signed a deal. While N4 have no signed deal as yet, they do have a collaboration with one of the biggest pharma`s in the world that is likely to lead to a deal and they are just about to set off on a deal seeking mission to Japan paid for by the UK government. | hughwilson | |
09/2/2018 11:41 | The nanomedicine market is set to be worth $350 billion by 2025 The attraction of the Nuvec side of the business is that to develop medicines for this market costs 100's of millions. N4P don't get involved in that and will just (hopefully) license out Nuvec as a drug delivery mechanism for the pharmas / biotechs whose objective is to take a drug through the costly process. Yet, despite not having any of the expense, they can still negotiate milestones for any drug they license Nuvec out for and negotiate a royalty if the drug ever reaches the market. All there in the November presentation :- | nick2412 | |
09/2/2018 11:38 | The difference I assume is they have a fully approved and patent protected product | jimbobaroony | |
09/2/2018 11:28 | escapetohome, I fully expect a bid to come in. What gives me comfort is that Nigel has a good idea of the value that can be created in N4 and would not sell it cheap.I think a price of about £200m would secure in in the near term but if it is allowed to build then it would be much more. The price of N4 is stupid at the moment and I do not think the market or investors has the vision to see the wealth creation that is possible here. The company I spoke of yesterday that rose 44% in one day because of signing just one nanoparticle deal is valued at £97 million and yet here we are with all the potential and big backers at the £20m mark. Crazy but it is what it is. Fully expect us to be multiples of where we are now in the near future. | hughwilson | |
09/2/2018 11:14 | Not a chance in a trillion years you will get my shares at this price is my response to any company stalking n4p with a view to making a bid. | escapetohome | |
09/2/2018 10:53 | I should add that I believe that the trial will be a complete success. Given the amount of warrant money already in plus that which could flow in between now and April, I believe that Nigel will have sufficient capital to go it alone with the full trials giving them 10-12% royalties in a billions of dollars market. That not only shows the quality of Nigel as a CEO but also the confidence in him by the main backers. | hughwilson | |
09/2/2018 10:45 | Urigem, The viagra trials are ongoing. N4 had already notified the market that trials would start in January so no RNS was required. Results will be by the end of April but in effect could be anytime during April, it just depends on how the tests go. | hughwilson | |
09/2/2018 10:42 | Hugh seems to be AWOL | keithlemon | |
09/2/2018 09:28 | Time to continue the rerate to 37p:))) | ch1rp | |
09/2/2018 08:52 | I wish advfn would sort their issues out !! | jakleeds | |
09/2/2018 08:26 | Missed that , thought I would wait and was just about to take some , but limits were tiny. Never mind | urigem | |
09/2/2018 08:24 | As we move North you'll find others have the confidence we're climbing out of the dip. | parob | |
09/2/2018 08:20 | Another 17440 added to my holding too. | parob | |
09/2/2018 08:12 | I just managed to add some more at 22.3p. Seems a good price to me. | bdog51 | |
09/2/2018 07:42 | with a 1000 point drop one the dow, I could get a good change to add. I must admit i didnt thin we would get this low, so need to stick by my plans and add on the weakness, although my top ups the other day now look poorly timed - hey Ho. | urigem |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions